BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22213684)

  • 41. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control.
    Kwok WH; Choi TLS; Tsoi YYK; Leung GNW; Wan TSM
    J Chromatogr A; 2017 Mar; 1490():89-101. PubMed ID: 28215405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes.
    Mazzarino M; Cesarei L; de la Torre X; Fiacco I; Robach P; Botrè F
    J Pharm Biomed Anal; 2016 Jan; 117():47-60. PubMed ID: 26342446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes.
    Görgens C; Guddat S; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1102-7. PubMed ID: 25070041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
    Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
    Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
    Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
    Lu J; Wang X; Xu Y; Dong Y; Yang S; Wu Y; Qin Y; Wu M
    Analyst; 2011 Feb; 136(3):467-72. PubMed ID: 21113546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated sample preparation for the detection and confirmation of hypoxia-inducible factor stabilizers in urine.
    De Wilde L; Roels K; Deventer K; Van Eenoo P
    Biomed Chromatogr; 2021 Feb; 35(2):e4970. PubMed ID: 32840903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Viet LN
    Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
    Sobolevsky T; Rodchenkov G
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection and characterization of betamethasone metabolites in human urine by LC-MS/MS.
    Matabosch X; Pozo OJ; Monfort N; Pérez-Mañá C; Farré M; Segura J; Ventura R
    Drug Test Anal; 2015 Aug; 7(8):663-72. PubMed ID: 25545348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LC-MS/MS detection of unaltered glucuronoconjugated metabolites of metandienone.
    Esquivel A; Pozo OJ; Garrostas L; Balcells G; Gómez C; Kotronoulas A; Joglar J; Ventura R
    Drug Test Anal; 2017 Apr; 9(4):534-544. PubMed ID: 27237125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing.
    Guddat S; Fußhöller G; Beuck S; Thomas A; Geyer H; Rydevik A; Bondesson U; Hedeland M; Lagojda A; Schänzer W; Thevis M
    Anal Bioanal Chem; 2013 Oct; 405(25):8285-94. PubMed ID: 23877183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.
    Thomas A; Kohler M; Schänzer W; Kamber M; Delahaut P; Thevis M
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in vitro metabolism of the 'designer' steroid estra-4,9-diene-3,17-dione between the equine, canine and human: identification of target metabolites for use in sports doping control.
    Scarth JP; Clarke AD; Teale P; Pearce CM
    Steroids; 2010 Oct; 75(10):643-52. PubMed ID: 20381511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism.
    Pozo OJ; Lootens L; Van Eenoo P; Deventer K; Meuleman P; Leroux-Roels G; Parr MK; Schänzer W; Delbeke FT
    Drug Test Anal; 2009 Nov; 1(11-12):554-67. PubMed ID: 20355172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations.
    Thevis M; Thomas A; Pop V; Schänzer W
    J Chromatogr A; 2013 May; 1292():38-50. PubMed ID: 23332783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.